Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment

计划入组 250 人 · 首次发布于 2020 年 12 月 17 日

Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH

计划入组 6 人 · 首次发布于 2019 年 9 月 23 日

Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients

计划入组 557 人 · 首次发布于 2019 年 3 月 7 日

Rebmab 100

Rebmab-200

Remab6

GENMAB K.K.

Japan

Genmab B.V.

Belgium

Genmab US, Inc.

United States

Biocytogen Secures Japan Patent for RenMab Platform, Strengthening Global IP Portfolio for Fully Human Antibody Discovery

Biocytogen Reaches Clinical Milestone as First Patient Dosed in IDEAYA's B7H3/PTK7 Bispecific ADC Phase 1 Trial

Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease